Microarray Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Microarray Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Microarray Market

5.1. Covid-19: Microarray Industry Impact
5.2. Microarray Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Microarray Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Microarray Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Microarray Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing incidence of cancer worldwide
6.1.1.2. Increasing expenditure on research and development in the healthcare sector
6.1.2. Market Restraints
6.1.2.1. Stringent Regulations
6.1.3. Market Opportunities
6.1.3.1. Growing awareness regarding personalized medicines
6.1.3.2. Increasing preference for DNA based microarrays

Chapter 7. Global Microarray Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Microarray Market Revenue by Market Players (2016 -2019)
7.1.1.2. MicroarrayMarket Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Microarray Market, By Product

8.1. Microarray Market, by Product, 2017-2030
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Software & Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microarray Market, By Type

9.1. Microarray Market, by Type, 2017-2030
9.1.1. DNA Microarrays
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Protein Microarrays
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Other Microarrays
9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microarray Market, By Application

10.1. Microarray Market, by Application, 2017-2030
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Diseases Diagnostics
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Microarray Market, By End User

11.1. Microarray Market, by End User, 2017-2030
11.1.1. Research & Academic Institutes
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical & Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other End Users
11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Microarray Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2017-2030)
12.1.2. Market Revenue Forecast by Type(2017-2030)
12.1.3. Market Revenue Forecast by Application (2017-2030)
12.1.4. Market Revenue Forecast by End User (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017-2030)
12.2.2. Market Revenue Forecast by Type (2017-2030)
12.2.3. Market Revenue Forecast by Application (2017-2030)
12.2.4. Market Revenue Forecast by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017-2030)
12.3.2. Market Revenue Forecast by Type (2017-2030)
12.3.3. Market Revenue Forecast by Application (2017-2030)
12.3.4. Market Revenue Forecast by End User (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017-2030)
12.4.2. Market Revenue Forecast by Type (2017-2030)
12.4.3. Market Revenue Forecast by Application (2017-2030)
12.4.4. Market Revenue Forecast by End User (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017-2030)
12.5.2. Market Revenue Forecast by Type (2017-2030)
12.5.3. Market Revenue Forecast by Application (2017-2030)
12.5.4. Market Revenue Forecast by End User (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)

Chapter 13. Company Profiles

13.1. Illumina, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Agilent Technologies, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. Merck & Co., Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. Arrayit Corporation
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. GE Healthcare
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Molecular Devices, LLC
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. Affymetrix
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Report Details

  • Report Code:36906
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:January 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers